98 related articles for article (PubMed ID: 28444835)
21. Monitoring of cytomegalovirus reactivation during induction and nontransplant consolidation of acute leukemia.
Lunghi M; Riccomagno P; De Paoli L; Vendramin C; Conconi A; Gaidano G; Rossi D
Am J Hematol; 2009 Oct; 84(10):697-8. PubMed ID: 19691101
[No Abstract] [Full Text] [Related]
22. Urine protein analysis by gel electrophoresis and laser densitometry after chemotherapy in pediatric cancer patients.
Mertens R; Granzen B; Vogt K; Melzer H; Mann H
Pediatr Hematol Oncol; 2000; 17(5):365-74. PubMed ID: 10914046
[TBL] [Abstract][Full Text] [Related]
23. Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study.
Lilly MB; Ottmann OG; Shah NP; Larson RA; Reiffers JJ; Ehninger G; Müller MC; Charbonnier A; Bullorsky E; Dombret H; Brigid Bradley-Garelik M; Zhu C; Martinelli G
Am J Hematol; 2010 Mar; 85(3):164-70. PubMed ID: 20131302
[TBL] [Abstract][Full Text] [Related]
24. Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Aldoss I; Gaal K; Al Malki MM; Ali H; Nakamura R; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1900-1903. PubMed ID: 27346662
[TBL] [Abstract][Full Text] [Related]
25. [Optic neuritis induced by Dasatinib in patients with Ph(+) acute lymphoblastic leukemia: a case report].
Fu L; Shen L; Bian JJ; Li L; Su YX; Zuo JM; Meng ML; Lu Y; Ge SY; Wang DC
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):608. PubMed ID: 37749048
[No Abstract] [Full Text] [Related]
26. [Pharmacological properties and clinical efficacy of dasatinib hydrate (Sprycel), an anticancer drug for chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia].
Fujii Y; Amano M; Seriu T
Nihon Yakurigaku Zasshi; 2009 Sep; 134(3):159-67. PubMed ID: 19749489
[No Abstract] [Full Text] [Related]
27. Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate.
Brave M; Goodman V; Kaminskas E; Farrell A; Timmer W; Pope S; Harapanhalli R; Saber H; Morse D; Bullock J; Men A; Noory C; Ramchandani R; Kenna L; Booth B; Gobburu J; Jiang X; Sridhara R; Justice R; Pazdur R
Clin Cancer Res; 2008 Jan; 14(2):352-9. PubMed ID: 18223208
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus in hematological malignancies.
Bakhshi S; Biswas B
Indian Pediatr; 2013 Feb; 50(2):193-4. PubMed ID: 23474925
[No Abstract] [Full Text] [Related]
29. [Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib].
Hoshino T; Tahara K; Miyawaki K; Hatsumi N; Takada S; Miyawaki S; Sakura T
Rinsho Ketsueki; 2010 Mar; 51(3):181-8. PubMed ID: 20379112
[TBL] [Abstract][Full Text] [Related]
30. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.
Talpaz M; Shah NP; Kantarjian H; Donato N; Nicoll J; Paquette R; Cortes J; O'Brien S; Nicaise C; Bleickardt E; Blackwood-Chirchir MA; Iyer V; Chen TT; Huang F; Decillis AP; Sawyers CL
N Engl J Med; 2006 Jun; 354(24):2531-41. PubMed ID: 16775234
[TBL] [Abstract][Full Text] [Related]
31. [Hepatitis and cytomegalovirus in patients with acute leukemia].
Marés Bermúdez J; Plaja Román P; Calico I; Javier Manchón G; Ortega Aramburu JJ
Sangre (Barc); 1988 Jun; 33(3):202-5. PubMed ID: 2845589
[No Abstract] [Full Text] [Related]
32. Cross-Intolerance With Dasatinib Among Imatinib-Intolerant Patients With Chronic Phase Chronic Myeloid Leukemia.
Khoury HJ; Goldberg SL; Mauro MJ; Stone RM; Deininger MW; Bradley-Garelik MB; Mohamed H; Guilhot F
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):341-349.e1. PubMed ID: 27133948
[TBL] [Abstract][Full Text] [Related]
33. The impact of dasatinib on pregnancy outcomes.
Cortes JE; Abruzzese E; Chelysheva E; Guha M; Wallis N; Apperley JF
Am J Hematol; 2015 Dec; 90(12):1111-5. PubMed ID: 26348106
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report.
Kostos L; Burbury K; Srivastava G; Prince HM
Platelets; 2015; 26(8):809-11. PubMed ID: 26029798
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus disease in children with acute lymphoblastic leukemia.
Jain R; Trehan A; Mishra B; Singh R; Saud B; Bansal D
Pediatr Hematol Oncol; 2016 May; 33(4):239-47. PubMed ID: 27285991
[TBL] [Abstract][Full Text] [Related]
36. Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure.
Sonmez M; Cobanoglu U; Ovali E; Omay SB
J Clin Pharm Ther; 2008 Jun; 33(3):329-30. PubMed ID: 18452422
[No Abstract] [Full Text] [Related]
37. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
38. The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib.
Morishita T; Hayakawa F; Sugimoto K; Iwase M; Yamamoto H; Hirano D; Kojima Y; Imoto N; Naoe T; Kiyoi H
Oncotarget; 2016 Aug; 7(35):56241-56252. PubMed ID: 27494842
[TBL] [Abstract][Full Text] [Related]
39. Sustained remission in a patient with PDGFR-beta-rearranged T-lymphoblastic lymphoma and complete remission with dasatinib.
Shah KP; Carroll CM; Mosse C; Yenamandra A; Borinstein SC
Pediatr Blood Cancer; 2020 Jan; 67(1):e28026. PubMed ID: 31571404
[No Abstract] [Full Text] [Related]
40. The FDA approves new leukemia drug; expands use of current drug.
FDA Consum; 2006; 40(6):5. PubMed ID: 17338066
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
